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Objective: The outcomes in pregnant patients with bicuspid aortic valves (BAVs) are rarely reported,
despite the potentially critical nature of the condition. The aim of this study is to present the clinical
complications of BAV in pregnancy.
Materials and methods: A MEDLINE database search and a Google internet search were conducted to ﬁnd
literature on BAV in pregnancy published between 1980 and 2012.
Results: BAV in pregnancy can lead to critical cardiovascular events including aortic dissection, aortic
valve disorders, and infective endocarditis; some of these complications may lead to poor maternal
outcomes or fetal demise. No differences were noted in either maternal or fetal mortality between
syndromic and nonsyndromic pregnant patients with BAV (maternal: 50% vs. 28.6%; p ¼ 0.4959; fetal:
25% vs. 0%; p ¼ 0.1987). The peak and mean pressure gradients across the aortic valve increased
signiﬁcantly with advancing gestational trimester; a remarkable decrease in peak pressure gradients was
seen postpartum. The calculated aortic valve area showed a signiﬁcant decrease in the third trimester
compared with the prepregnancy value, as well as a considerable postpartum decrease.
Conclusion: Syndromic and nonsyndromic BAVs may have similar importance for maternal and fetal
mortality. Aortic valve stenosis may become more severe with advancing pregnancy, with attenuation
after delivery. Patients may require surgical intervention for the complications of BAV during pregnancy.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Bicuspid aortic valve (BAV) is the most common congenital
cardiac malformation, occurring in 1e2% of the population [1]. The
malformation involves both the valve and the aorta, and patients
require lifelong surveillance [2]. The critical complications of this
condition are well described and include aortic stenosis, aortic
regurgitation, infective endocarditis, and aortic dissection [3]; of
these, isolated aortic stenosis is the most common associated dis-
order [4]. Pregnant women with a severely stenotic BAV may
experience cardiovascular deterioration, with 10e30% of this pa-
tient subset experiencing complications that, in turn, lead to a high
therapeutic abortion rate. Women with mildly to moderately ste-
notic BAVs may not experience these complications. Cardiac issues
during pregnancy, such as deteriorating heart function, angina, and
arrhythmias, may require prompt surgical intervention, posingHospital of Putian, Teaching
Street, Chengxiang District,
hina.
inyuan@126.com.
bstetrics & Gynecology. Publishedrisks to both mother and fetus [5]. However, the natural progres-
sion of this condition during pregnancy and its effects on maternal
and fetal outcomes have not been sufﬁciently elucidated at this
point.
Materials and methods
A MEDLINE database search and a Google internet search was
conducted of the English literature for articles published between
1980 and 2012. “Bicuspid aortic valve” and “pregnancy” were the
two main search terms; once articles were collected, the reported
complications of BAV were carefully scrutinized. A total of 100
publications were obtained through these searches, but 50 were
unrelated to BAV and pregnancy and were therefore excluded.
Review articles with no substantial data (8 articles), original articles
or case reports with missing or obscure data (12 articles), articles
oriented toward the fetus rather than the parturient (6 articles),
and articles describing the onset of cardiac events during the
postpartum period (1 article) were excluded. A total of 23 reports
were included in this study.
The quantitative data reported for patients with a stenosed BAV
were analyzed and compared using the paired or unpaired t test.by Elsevier Taiwan LLC. All rights reserved.
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p value <0.05 was considered statistically signiﬁcant.
Results
A total of 33 pregnant women, described in 23 reports, devel-
oped cardiovascular sequelae of BAV including aortic dissection,
aortic stenosis, aortic regurgitation, and infective endocarditis.
Aortic stenosis was the most common complication, with aortic
dissection the second most common (Table 1).
Aortic dissection
Aortic dissection occurred in 11 pregnant women, described in
10 reports [6e15]. Their age was 30.4 ± 5.1 years (range, 19e36
years; median, 30 years). Nine patients developed aortic dissection
during pregnancy, at a mean of 32.7 ± 5.6 weeks' gestation (range,
21e38 weeks; median, 32 weeks), one patient developed the
complication 2 weeks after a vaginal delivery, and the ﬁnal patient
developed a dissection on Day 2 after cesarean section. Four of the
11 patients (36.4%) were primigravid. The onset symptoms were
described in eight patients: chest pain in four patients (50%), and
one patient (12.5%) each with epigastric pain, chest discomfort,
syncope, and shortness of breath. Five patients (45.5%) had a delay
of 61.2 ± 91.2 hours (range, 3e216 hours; median, 12 hours) from
symptom onset to hospital admission, and four patients (36.4%)
had a delay of 16 ± 10.3 hours (range, 1e24 hours; median, 19.5
hours) from admission to diagnosis. The diagnosis was established
by noninvasive imaging methods (echocardiography, ultrasound,
computed tomography, or magnetic resonance imaging) in 10 pa-
tients (90.9%); in one patient (9.1%), the diagnosis was made at
autopsy. The aortic dissectionwas type A in 10 patients (90.9%) and
type B in one patient (9.1%). The diameter of the aorta at the widest
part of the dissection was recorded in four patients, with a mean
value of 46 ± 17.5 mm (range, 29e70mm;median, 42.5 mm). Three
patients (27.3%) had associated aortic valve regurgitation, and one
patient (9.1%) had mitral valve prolapse.
BAV was the sole risk factor for aortic dissection in six patients
(54.5%), three patients (27.3%) had Turner syndrome (1 with asso-
ciated coarctation of the aorta), one patient (9.1%) had Marfan
syndrome, and one patient (9.1%) used tobacco. Urgent aortic repair
was performed upon dissection diagnosis in nine patients (81.8%), a
2-hour delay occurred in one patient (9.1%), and one patient (9.1%)
experienced sudden death before surgery could be performed.
Ascending aorta replacement was performed in four patients
(36.4%), ascending aorta replacement with aortic valve replace-
ment in one patient (9.1%), the Bentall operation in three patients
(27.3%), and aortic valve replacement with aortic root plication and
descending aorta replacement in one patient (9.1%). Urgent cesar-
ean section for aortic dissection was performed in ﬁve patients
(45.5%) at 33 ± 3.6 weeks' gestation (range, 28e37 weeks; median,
32 weeks). Aortic surgery was performed at a mean of 32.3 ± 3.8
weeks' gestation (range, 28e37.3 weeks; median, 32 weeks). Seven
(63.6%) patients survived; one patient (9.1%) died suddenly beforeTable 1
Complications of bicuspid aortic valve during pregnancy.
Complication Report, n (%) Case, n (%)
Aortic stenosis 9 (37.5) 18 (52.9)
Aortic dissection 10 (41.7) 11 (32.4)
Infective endocarditis 3 (12.5) 3 (8.8)
Aortic regurgitation 2 (8.3)a 2 (5.9)a
a One patient from one report had aortic valve regurgitation caused by infective
endocarditis.the diagnosis could be made, and three patients (27.3%) died sud-
denly after aortic repair. The mortality was 36.4%.
Patients with aortic dissection were further divided into two
subgroups: syndromic and nonsyndromic. The former included
patients withMarfan or Turner syndrome (n¼ 4), and the latter had
patients with no features of any syndrome (n ¼ 7). No differences
were noted in either maternal or fetal mortality between the syn-
dromic and nonsyndromic pregnant patients (maternal: 50% vs.
28.6%; p ¼ 0.4959; fetal: 25% vs. 0%; p ¼ 0.1987).
Aortic valve stenosis
The transvalvular pressure gradients and calculated aortic valve
areas in 18 pregnant patients with stenotic BAVs were collected
from nine reports [16e24]. The mean patient age was 27.0 ± 6.9
years (range, 16e38 years; median, 28 years). Severe aortic stenosis
was present in 15 patients (83.3%) and moderate stenosis in three
patients (16.7%). Four patients (25%) manifested congestive heart
failure. Six patients required cesarean section at a mean gestational
age of 33.8 ± 4.5 weeks (range, 28e39 weeks; median, 33.5 weeks).
The fetal monitoring was described for eight patients: seven trac-
ings (87.5%) indicated good fetal well-being but one fetus (12.5%)
exhibited “distress” and an urgent cesarean delivery was per-
formed [19].
Surgical intervention for aortic valve stenosis was required in six
patients (33.3%) of which four (66.7%) had balloon aortic valvulo-
plasty during pregnancy [18,20,23], and two (33.3%) underwent
aortic valve replacement after delivery [16,22]. The peak and mean
pressure gradients across the aortic valve increased signiﬁcantly
with advancing pregnancy trimester (peak: 92.8 ± 13.9 mmHg vs.
65.3 ± 19.6 mmHg; p ¼ 0.0232; mean: 48.5 ± 7.7 mmHg vs.
35.0 ± 4.8 mmHg; p ¼ 0.0249). A remarkable decrease in the peak
pressure gradients was seen postpartum, compared with the values
noted in the third trimester (54.8 ± 29.4 mmHg vs.
92.8 ± 13.9 mmHg; p ¼ 0.0310; Fig. 1). The calculated aortic valve
area showed a signiﬁcant decrease in the third trimester compared
with its prepregnancy value (0.74 ± 0.04 cm2 vs. 1.03 ± 0.26 cm2;
p ¼ 0.0343); this value again decreased considerably in the post-
partum period, although the reduction in area did not reach sta-
tistical signiﬁcance (Fig. 2).
Aortic valve regurgitation
Two young pregnant patients with BAV developed aortic
regurgitation during pregnancy. The ﬁrst patient was 16 years old
and presented with dyspnea and orthopnea at 32 weeks' gestation,
then with breathlessness at 34 weeks' gestation [25]. She under-
went cesarean delivery at 34 weeks due to the deterioration in her
heart function. Her female baby did well at birth, with Apgar scores
of 3 and 9 at 1 minute and 5 minutes, respectively. A maternal
cardiac function evaluation performed 3 weeks after delivery
showed a left ventricular diastolic dimension of 60 mm and a
valvular pressure gradient of 33 mmHg.
The second patient was a 23-year-old womanwith severe aortic
valve regurgitation present at 21 weeks' gestation. Urgent aortic
valve replacement was performed but the patient experienced
subsequent intrauterine fetal demise [26].
Infective endocarditis
Three pregnant women with BAV experienced infective endo-
carditis (Table 2) [26e28]. One patient died suddenly, and the
diagnosis was made by autopsy. The other two patients underwent
aortic valve replacement for decreased heart function and both
Fig. 1. Peak and mean pressure gradients across the stenosed aortic valve before, during, and after pregnancy.
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mature fetus exhibited distress.
Discussion
Antepartum type A aortic dissection associated with BAV was
previously evaluated by Immer et al [29]. They found that patients
with Marfan syndrome are younger at dissection onset than the
BAV group as a whole, with a median age of 27.8 ± 3.7 years. In
recent years, women with Turner syndrome have been able to
become pregnant using oocyte donation.With increased pregnancy
and live-birth rates have come high rates of maternal complications
such as eclampsia, and the estimated mortality due to aorticFig. 2. Calculated aortic valve area bedissection or rupture during pregnancy is 2% [30]. Boissonnas et al
[11] evaluated seven patients with Turner syndrome and BAV,
determining that BAV is an absolute contraindication to oocyte
donation because of the potential risk of aortic dissection. In the
present study, however, the lack of statistical difference in maternal
and fetal mortality between syndromic and nonsyndromic sub-
groups of patients with BAV indicates that the risks are due to the
condition itself, not the presence of a syndrome, in pregnant
women.
In pregnant patients, proximal aortic dilation can progress to
ectasia or aneurysm, and the risk of aortic dissection may be
increased [31]. The presence of aortic root dilation can certainly
indicate risk, but dissection can occur even in the absence offore, during, and after pregnancy.
Table 2
Bicuspid aortic valve (BAV) with infective endocarditis in pregnancy.
Patient Age Gestation
week
Symptom Examination BAV Vegetation Surgery Maternal
outcome
Fetal
outcome
1 21 35 Sudden death Autopsy Stenosed 5 mm, extending into
the ostium of the left
main coronary artery
No Died Died
2 31 36 Fever, weakness, chest pain,
painful skin over her right
leg, and dyspnea
Transesophageal
echocardiography
Severe
regurgitation
18 mm, attached to the
right coronary cusp
Urgent cesarean followed
by aortic valve replacement
at 36 weeks
Alive Alive
3 23 21 Fever at 21 weeks, worsening
shortness of breath, orthopnea,
and lower extremity edema at
24 weeks
Transesophageal
echocardiography
Severe
regurgitation
12 mm, attach to both
cusps
Urgent aortic valve replacement
at 24 weeks, induced abortion
after aortic valve replacement
due to fetal distress
Alive Died
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ommended for patients with Marfan syndrome and ascending
aortic dilation of >50 mm [33]. In patients with an aortic diameter
of <50 mm, surgical intervention can be considered for rapid pro-
gression, a family history of premature aortic dissection, and the
presence of aortic regurgitation that is greater than mild-degree.
Because of the increased risk of fetal complications associated
with urgent surgery for dissection during pregnancy, a prophylactic
elective repair is preferred. Recent guidelines recommend elective
surgery prior to pregnancy for women with an aortic root of
>47 mm [34]. Valve-sparing aorticroot replacement has been
advocated in young patients with Marfan syndrome in order to
avoid the anticoagulation therapy necessary after valve replace-
ment [35e38].
An aortic valve area 1.0 cm2 or a transvalvular pressure
gradient64mmHg deﬁnes severe aortic stenosis [39]. Serial brain
natriuretic peptide (BNP) measurements show changes in the
transvalvular pressure gradient and aortic valve area with
increasing BNP values [18]. The changing pressure gradient and
aortic valve area in the third trimester reﬂect the increased preload
of advanced pregnancy; this may lead to complications such as
arrhythmia, myocardial ischemia, congestive heart failure, and
cardiogenic shock [40]. The transvalvular pressure gradient and jet
velocity measured during pregnancy are higher than in the post-
partum state, however, the reduction in the transvalvular gradient
after pregnancy may not be associated with a reduction in the
severity of the stenosis [41]. Aortic stenosis often causes adverse
cardiac effects in parturients due to the increased cardiac strain,
resulting in heart failure and myocardial ischemia. Two decades
ago, a large cohort study revealed that pregnant womenwith aortic
stenosis have maternal and fetal mortality as high as 11% and 4%,
respectively [42]. It has been suggested that women should un-
dergo surgical intervention for stenosed BAV before getting preg-
nant [22]. Severe aortic stenosis during pregnancy may warrant
urgent percutaneous valvuloplasty to reduce the peak pressure
gradient to a normal value [21].
About 25% of patients with BAV develop some degree of aortic
insufﬁciency during their lifetime [43]. Pure valve regurgitation is
deﬁned as Grades 3e4 of 4, with a transvalvular pressure gradient
of <30 mmHg; the risk of valve regurgitation is suggested to be
secondary to aortic dilation [44]. Prolapse, restriction, and retrac-
tion are the most frequent concepts employed to describe the cusp-
related mechanism of regurgitation [45]. The proposed aortic valve
repair techniques have been described by Pettersson and Ram-
ankutty [46].
Congenital BAV is themost commonrisk factor forendocarditis of
the aortic valve [47], although two-thirds of BAV patients are not
actuallydiagnoseduntil after theonsetof infectiveendocarditis [48].
The acute onset of aortic regurgitation caused by infective endo-
carditis of BAV has been reported [49], as has perivalvular abscess[50]. Reportedly, 82% of patientswith BAV and infective endocarditis
require surgery, with overall mortality and surgical mortality of 14%
and 9%, respectively [51]. Prophylactic antibiotics are necessary in
patients with BAV undergoing invasive procedures [1].
Patients with BAV are prone to developing thrombosis on the
valve surface or in areas of calciﬁcation, where diffuse ﬁbrosis and
neovessel formation often occur [52]. Spontaneous thrombosis of a
native aortic valve is an uncommon event that usually follows local
trauma such as cardiac surgery or left-heart catheterization [53]. In
patients with BAV, severe calciﬁc stenosis and subsequent cardiac
catheterization may play an important role in thrombus formation
[54]. Dhoble et al [55] reported a 21-year-old pregnant womanwith
cor triatriatum sinister and BAV who developed bilateral pulmo-
nary emboli, for which she received treatment with low molecular
weight heparin. No valve calciﬁcationwas noted in this patient; this
could indicate that her pulmonary embolism was not directly
related to BAV.
All patients described in the literature with BAV in pregnancy
experienced cardiovascular complications including aortic dissec-
tion, aortic valve disorders, and infective endocarditis. Some pa-
tients experienced either poor maternal outcomes or fetal demise.
However, it is possible that BAV in pregnancy may have excellent
clinical outcomes in the majority of patients; these patients are not
reported as they do not require speciﬁc interventions. The critical
cardiovascular events described in patients with BAV may actually
occur only occasionally.
The present study discovered two main new ﬁndings. One is the
lack of a difference in maternal and fetal mortality between syn-
dromic and nonsyndromic patients with BAV; the other is the
exaggerated aortic valve stenosis present in advanced pregnancy
that may be attenuated after delivery. Despite this expected post-
partum improvement, surgical intervention may still be required
during pregnancy in critical patients. The limited patient population
of this study may warrant deliberate, prospective investigations in
the future.
BAV in parturients may carry a signiﬁcant risk for cardiovascular
complications and may even lead to the death of both the mother
and the fetus. Prepregnancy evaluation of cardiac function and
vigilant antepartum surveillance are important components of a
safe pregnancy for women with BAV.Conﬂicts of interest
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